Market Overview

Teva Pharmaceutical Industries Limited (NYSE: TEVA)

12.19 +0.65 (5.63%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2021
Pre-Market
EPS:
REV:
0.76
4.357B



Q4 2020
Pre-Market
EPS:
REV:
0.62
4.468B



Q3 2020
Pre-Market
EPS:
REV:
0.58
4.264B



Q2 2020
Pre-Market
EPS:
REV:
0.6
4.337B
0.53
3.94B


Q1 2020
Pre-Market
EPS:
REV:
0.6
4.295B
0.59
4.15B
0.76
4.357B
28.81%
4.99%
Q4 2019
Pre-Market
EPS:
REV:
0.53
4.559B
0.61
4.35B
0.62
4.468B
1.64%
2.71%
Q3 2019
Pre-Market
EPS:
REV:
0.68
4.529B
0.58
4.22B
0.58
4.264B
0%
1.04%
Q2 2019
Pre-Market
EPS:
REV:
0.78
4.701B
0.57
4.25B
0.6
4.337B
5.26%
2.05%
Q1 2019
Pre-Market
EPS:
REV:
0.94
5.065B
0.58
4.38B
0.6
4.295B
3.45%
-1.94%
Q4 2018
Pre-Market
EPS:
REV:
0.93
5.459B
0.54
4.53B
0.53
4.559B
-1.85%
0.64%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!